Skip to main content

Clonorchiasis Research Report- Global Forecast Till 2023


The global clonorchiasis market is expected to grow at a CAGR of 5.4% during the forecast period.
Clonorchiasis is an infectious disease caused by the Chinese liver fluke Clonorchis sinensis. Clonorchiasis is dominant in Asian countries and regions, including South Korea, China, Northern Vietnam, and far-eastern Russia. China has the largest population of infected people. In the acute phase, heavier infections can cause fever, chills, epigastric pain, tender hepatomegaly, mild jaundice, and eosinophilia occur. Chronic cholangitis in heavy infections, which may progress to atrophy of liver parenchyma, portal fibrosis, and cirrhosis. Increasing prevalence of clonorchiasis, changing lifestyle, poor diet, and increasing geriatric population have driven the growth of the market. Moreover, increasing healthcare expenditure has fuelled the growth of the market. On the other hand, high cost of the treatment may slow the market growth.
Market Key Players
The key players for the global clonorchiasis market are Pfizer (U.S), Bayer AG (Germany), Provet (Switzerland), Virbac (India), Cipla (India), Novartis AG (Switzerland), CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (U.S.), Arsanis, Inc. (Austria), Novabiotics (U.K.), GlaxoSmithKline plc. (U.K.), and Teva Pharmaceutical Industries Ltd (Taiwan). 
Market Segmentation
The global clonorchiasis market is segmented on the basis of parasites, therapy, and end users.
On the basis of the parasites, the market is segmented into Clonorchis sinensis, Opisthorchis viverrini, Opisthorchis felineus, and others.
On the basis of the therapy, the market is segmented into diagnosis and treatment. The diagnosis is further segmented into microscopic examination, X-ray, serologic tests, and others. The treatment is sub-segmented into praziquantel, cesol, cisticid, biltricide, and others.
On the basis of end users, the market is segmented into hospital, clinics, and others.
Regional Analysis
The Americas dominate the global clonorchiasis market owing to a large geriatric population, strong government support for research & development, and high healthcare spending. According to the Centers for Disease Control and Prevention in 2014, over 14.8 million of the U.S. population had GI diseases. Increasing prevalence of GI diseases has boosted the market growth. Additionally, poor diet and increasing awareness has fuelled the growth of the market. 
Europe is the second leading market across the globe, which is followed by Asia Pacific. Asia Pacific is the fastest growing market for Clonorchiasis. Asia Pacific clonorchiasis market is majorly driven by India, China, and South Korea owing to a huge patient pool, and continuously developing healthcare sector have fuelled the growth of the market. China has the largest population of infected people with Clonorchis sinensis. In 2013, over 13 million people were infected in China.
The Middle East and Africa contribute the least in the growth of the global clonorchiasis market. However, the Middle East is dominating the market of this region. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East market. However, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition. However, the growth of the African market is high due to the presence of opportunities for the development of the market.
About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
Office No. 524/528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
Maharashtra, India
+1 646 845 9312

Comments

Popular posts from this blog

Global Cowden Syndrome Market Technologies, Clinical Review and Industry Outlook To 2023

  Global Cowden Syndrome Market  Research Report: By Site (Breast, Thyroid, Colorectal, Kidney, Skin), Treatment (Genetic Testing, Chemotherapy, Targeted Therapy, Surgery & Radiation Therapy, Hormone Therapy), End User (Hospital & Clinics) - Forecast till 2023 Market Highlights Cowden syndrome is part of the PTEN hamartoma tumor syndrome. Cowden syndrome is characterized by a high risk of both benign and cancerous tumors of the breast, thyroid, endometrium, colorectal, kidney, and skin. The global Cowden syndrome market is expecting a healthy growth in the coming future. The global market is majorly driven by increasing Cowden syndrome patients across the globe. Additionally, increasing smoking population and rising consumption of alcohol have spurred the growth of the market. However, long time for approval and side effects of the treatment may hinder the growth of the market. Intended Audience Pharmaceutical Companies Government and private research companies Researc...

H. Pylori (Helicobacter Pylori) Test Market Top Company Profiles, Latest Technology, Global Size and Industry Trends

  H. Pylori (Helicobacter Pylori) Test Market Size, Revenue, Global Opportunity and Value Chain 2019 to 2023 H. Pylori (Helicobacter Pylori) Test Market Research Pune, India, October 2019/MRFR Press Release/- Market Research Future has published its Half-Cooked Research Report on the Global H. Pylori (Helicobacter Pylori) Test Market. The  H. Pylori (Helicobacter Pylori) Test Market size  analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue. Global H. Pylori (Helicobacter Pylori) Test Market, by Region North America US Canada Europe Spain Germany Italy France UK Rest of Europe Asia-Pacific Australia China Japan South Korea India Rest of Asia-Pacific Middle East & Africa UAE Saudi Arabia Egypt Rest of Middle East and Africa The report also appraises the supervisory scenarios which affect various decisions in the market. With a...

Insulating Paints And Coatings Market 2021 Share Acquire Huge Growth, Global Opportunities and Trends to 2026

  Exactitude Consultancy 2021 Press Release: Global Insulating Paints and Coatings Market Hygiene which is one of the important factors for the well-being of person has never been highlighted as it is spread in the era after the onset of Covid-19. Hand hygiene and hygiene of frequently touched surfaces has become of paramount importance. Household and commercial spaces have increasingly invested in the products which enhances the hygiene quality of the ecosystem. Apart from increasing the surface’s durability, appearance, corrosion resistance, etc., these coatings also protect from harmful disease-causing microbes. There is increasing need to protect surfaces, equipment, walls, textiles, food and other susceptible things from microbes which eventually finds the way to the humans. It is impossible to disinfect every time the object and use strong chemicals frequently. This requirement can be completed by Paints and Coatings market. The industrial paint segment, on the other hand, in...